These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31718444)

  • 1. Cardiomyocyte-Specific
    Thirugnanam K; Cossette SM; Lu Q; Chowdhury SR; Harmann LM; Gupta A; Spearman AD; Sonin DL; Bordas M; Kumar SN; Pan AY; Simpson PM; Strande JL; Bishop E; Zou MH; Ramchandran R
    J Am Heart Assoc; 2019 Nov; 8(22):e012792. PubMed ID: 31718444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucrose Nonfermenting-Related Kinase Enzyme-Mediated Rho-Associated Kinase Signaling is Responsible for Cardiac Function.
    Cossette SM; Bhute VJ; Bao X; Harmann LM; Horswill MA; Sinha I; Gastonguay A; Pooya S; Bordas M; Kumar SN; Mirza SP; Palecek SP; Strande JL; Ramchandran R
    Circ Cardiovasc Genet; 2016 Dec; 9(6):474-486. PubMed ID: 27780848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway.
    Zhu J; Li Q; Sun Y; Zhang S; Pan R; Xie Y; Chen J; Shi L; Chen Y; Sun Z; Zhang L
    J Am Heart Assoc; 2023 Sep; 12(18):e029631. PubMed ID: 37721135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca
    Suetomi T; Willeford A; Brand CS; Cho Y; Ross RS; Miyamoto S; Brown JH
    Circulation; 2018 Nov; 138(22):2530-2544. PubMed ID: 30571348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathway.
    Shen S; Wu G; Luo W; Li W; Li X; Dai C; Huang W; Liang G
    Phytomedicine; 2023 Jan; 108():154519. PubMed ID: 36332391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.
    Ye S; Huang H; Han X; Luo W; Wu L; Ye Y; Gong Y; Zhao X; Huang W; Wang Y; Long X; Fu G; Liang G
    Circ Res; 2023 Mar; 132(6):707-722. PubMed ID: 36786193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKIIδ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis.
    Willeford A; Suetomi T; Nickle A; Hoffman HM; Miyamoto S; Heller Brown J
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lycorine inhibits Ang II-induced heart remodeling and inflammation by suppressing the PI3K-AKT/NF-κB pathway.
    Tuo P; Zhao R; Li N; Yan S; Yang G; Wang C; Sun J; Sun H; Wang M
    Phytomedicine; 2024 Jun; 128():155464. PubMed ID: 38484625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB-mediated integrin-linked kinase regulation in angiotensin II-induced pro-fibrotic process in cardiac fibroblasts.
    Thakur S; Li L; Gupta S
    Life Sci; 2014 Jun; 107(1-2):68-75. PubMed ID: 24802124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-103a-3p contributes to angiotensin II-induced renal inflammation and fibrosis via a SNRK/NF-κB/p65 regulatory axis.
    Lu Q; Ma Z; Ding Y; Bedarida T; Chen L; Xie Z; Song P; Zou MH
    Nat Commun; 2019 May; 10(1):2145. PubMed ID: 31086184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.
    Ma E; Wu C; Chen J; Wo D; Ren DN; Yan H; Peng L; Zhu W
    Biomed Pharmacother; 2023 Sep; 165():115275. PubMed ID: 37541173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tax1 banding protein 1 exacerbates heart failure in mice by activating ITCH-P73-BNIP3-mediated cardiomyocyte apoptosis.
    Wu QQ; Yao Q; Hu TT; Wan Y; Xie QW; Zhao JH; Yuan Y; Tang QZ
    Acta Pharmacol Sin; 2022 Oct; 43(10):2562-2572. PubMed ID: 35948751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING activation in cardiomyocytes drives hypertrophy-associated heart failure via NF-κB-mediated inflammatory response.
    Wang L; Zhang S; Liu H; Gao L; He L; Chen Y; Zhang J; Yang M; He C
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166997. PubMed ID: 38142758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNRK regulates TGFβ levels in atria to control cardiac fibrosis.
    Thirugnanam K; Rizvi F; Jahangir A; Homar P; Shabnam F; Palecek SP; Kumar SN; Pan A; Bai X; Sekine H; Ramchandran R
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
    Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
    Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
    Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.